$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Cell culture of cardiomyocytes is a critical tool in modern cardiac research. Neonatal rat cardiomyocytes (NRCMs) are commonly used since the isolation and culture is easier than that of adult rat cardiomyocytes1. The NRCM method still has several limitations including a long isolation procedure and limited cell proliferation in the dish. There are numerous protocols for the isolation of NRCMs with most generally requiring 4-48 hr of work2–6. In addition, the cells are frequently isolated from 1 to 2-day old rat pups2,4–7; the timing of the birth can be unpredictable and conflict with other work in the lab. The isolations can be inefficient and wasteful if only a small amount of cells are needed for experiments. Most efforts on improving the workflow focus on reducing the isolation time, yet this does not solve the problems of timing the birth of the pups.
As alternatives, many labs utilize cardiomyocytes derived from embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs). However, the reprogramming and/or differentiation process can be very time consuming and costly as well. There can be other problems when using these cells as in vitro myocyte models. Both ESC- and iPSC- derived cardiomyocytes have been shown to exhibit differences in electrophysiology from primary cardiomyocytes8–10.
Dissociated NRCMs are capable of being stored for several days using refrigeration11, yet this does allow for long term storage. Liquid nitrogen is typically used to preserve cells for a greater period of time, but requires a cryoprotectant such as dimethyl sulfoxide (DMSO). Previous research has shown that the ideal concentration between 5-10% DMSO in the freezing media allows for cryopreservation of NRCMs, yet even then the viability remains low12. Although DMSO helps protect the cells during freezing, it can be toxic to cells at concentrations above 1.5%13. Previous studies have shown that slowly removing DMSO from the cells, may improve cell viability14.
We sought to improve the efficiency of NRCM cell-based assays by cryopreserving the cells following isolation. This allows for the cells to be thawed and used when necessary, reducing the frequency of isolations and consumption of animals. Using this method, we show that it is possible to cryopreserve NRCMs and thaw them for use at a later time. After thawing the cells maintain an acceptable viability and produce NRCM cultures that are positive for α-sarcomeric actinin (α-SA) and contract spontaneously.